Related Experiment Video

Updated: May 7, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.1K

TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which

Erina Takai1, Mitsutoshi Tsukimoto, Shuji Kojima

  • 1Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-shi, Chiba, Japan.

Plos One
|October 8, 2013
PubMed

Insights

Transforming growth factor-ß1 (TGF-β1) reduces cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) in lung cancer cells. This suggests PGE2 may counteract TGF-β1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-ß1 (TGF-β1) is a cytokine implicated in cancer and fibrosis.
  • The cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway plays a role in cell proliferation.
  • Epithelial-mesenchymal transition (EMT) is a key process in fibrosis and cancer metastasis.

Purpose of the Study:

  • To investigate the effect of TGF-β1 on the COX-2/PGE2 pathway in human lung cancer cells.
  • To determine the role of the COX-2/PGE2 pathway in TGF-β1-induced cell proliferation and EMT.
  • To explore the potential anti-fibrotic effects of PGE2.

Main Methods:

  • Human lung cancer A549 cells were treated with TGF-β1.
  • COX-2 and PGE2 levels were measured.
  • Cell proliferation and EMT markers (fibronectin, collagen I, actin remodeling) were assessed following treatment with TGF-β1, COX-2 inhibitors, PGE2, and specific PGE2 receptor agonists.

Main Results:

  • TGF-β1 treatment downregulated COX-2 expression and reduced PGE2 synthesis in A549 cells.
  • Inhibition of COX-2 or PGE2 receptor led to cell growth inhibition, suggesting autocrine proliferation signaling.
  • Exogenous PGE2 attenuated TGF-β1-induced growth inhibition.
  • PGE2 and EP4 agonists inhibited TGF-β1-induced EMT markers and actin remodeling, indicating an anti-fibrotic effect.

Conclusions:

  • TGF-β1 downregulates the COX-2/PGE2 pathway in lung cancer cells.
  • The COX-2/PGE2 pathway contributes to cancer cell proliferation.
  • PGE2 exhibits anti-fibrotic properties by inhibiting TGF-β1-induced EMT.
  • TGF-β1-induced suppression of COX-2/PGE2 signaling facilitates fibrotic EMT.

More Related Videos

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition06:02

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Published on: June 10, 2016

12.0K
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

10.1K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K